Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, announced today that its clinical cosmetics brand WELLAGE has been named No. 1 in the dermocosmetics category at the Brand of the Year 2026 in Korea, marking its eighth consecutive win.
Organized by the Korea Consumer Forum, it is one of the country’s largest consumer-voted awards, honoring brands that have made a strong impact over the past year. For this year’s event, more than 770,000 consumers participated in the voting, with winners selected based on a combination of online polls and telephone surveys.
Built on Hugel’s expertise in hyaluronic acid technology, WELLAGE offers clinically inspired skincare solutions designed to address a range of skin concerns. Its portfolio includes the signature Real Hyaluronic line, as well as products formulated with highly purified and concentrated active ingredients. The brand has continued to expand its offerings with lines such as Hyper PDRN, Hyper Peptide, and Hyper Toning, targeting issues including loss of firmness, dullness, enlarged pores, and uneven skin tone.
WELLAGE has maintained its No.1 ranking in the dermocosmetics category for eight consecutive years since its first award in 2019, in recognition of its specialized products for targeting dehydrated skin. The brand has also been expanding its global presence beyond the Asia-Pacific market, entering major global retail channels such as Sephora and OLIVE YOUNG in the U.S.
“We are delighted that WELLAGE has been highly recognized as a leading dermocosmetics brand for eight years in a row,” said Seanguk Ji, Executive Vice President of Hugel. “We will continue to strengthen our offerings and earn the trust of consumers in Korea and globally through differentiated product quality.”
About Hugel
Established in 2001, Hugel is a global leader in medical aesthetics, specializing in the production of injectables for skin rejuvenation, including botulinum toxin, hyaluronic acid dermal fillers, and skinboosters, as well as absorbable sutures and cosmetic products. With a proven track record of safety and quality, Hugel is deeply committed to advancing the industry through robust medical affairs, comprehensive training programs, and dynamic industry forums.
Over the past 20 years, the company has built a presence in approximately 70 countries and operates nine global subsidiaries across the U.S., Australia, Canada, Taiwan, China, Hong Kong, Singapore, and Thailand. Leveraging strong industry momentum, Hugel is well-positioned for continued growth and market expansion worldwide.
(Photo caption) Seung Lee (right), Director of Cosmetics Sales at Hugel, poses for a photo at the Brand of the Year 2026 ceremony held at The Shilla Seoul on September 1
